Putnam BioRevolution ETF (SYNB) Holdings $27.41 -0.09 (-0.33%) As of 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsRatingsBuy This Stock Top 38 SYNB HoldingsRankCompanyCurrent PriceWeightShares Held1TMOThermo Fisher Scientific$393.53-1.7%8.39%8262ABBVAbbVie$183.51+0.5%5.73%1,3403CTVACorteva$69.07+0.7%5.56%4,3324BIOBio-Rad Laboratories$224.08-1.3%5.06%1,0185NVZMYNovozymes A/S$69.75-1.0%4.94%4,1406AZNAstraZeneca$70.41+0.7%4.42%2,9437LLYEli Lilly and Company$713.99-0.2%4.20%2498ASNDAscendis Pharma A/S$162.00+1.2%4.03%1,2679GOOGLAlphabet$168.47-1.4%3.79%1,20010NVDANVIDIA$131.29-1.2%3.74%1,692 Get the Latest News and Ratings for SYNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. 11REGNRegeneron Pharmaceuticals$588.34-1.4%3.70%28612DDDuPont de Nemours$67.62-0.6%3.63%2,38213CDNSCadence Design Systems$315.51-0.4%3.15%60714AVTRAvantor$12.70-1.2%2.87%8,66915Net CashN/A2.83%138,75216DARDarling Ingredients$31.54-0.5%2.51%3,93017DHRDanaher$184.79-1.4%2.42%57818ICLRICON Public$127.99+0.8%2.30%64519NGVTIngevity$41.04-0.6%2.21%2,73820Symrise AGN/A2.19%1,03521ONONON$58.44-0.6%1.86%2,07822Danone Sedol B1y9tb3N/A1.82%1,16123Borregaard ASAN/A1.77%5,33024BMRNBioMarin Pharmaceutical$57.55-0.8%1.75%1,21625ARGXargenx$587.61+1.1%1.68%13926VRTXVertex Pharmaceuticals$436.00+0.5%1.65%16727PPGPPG Industries$110.18-0.9%1.61%72028TECHBio-Techne$46.78-1.1%1.33%1,11329ALNYAlnylam Pharmaceuticals$289.96+0.3%1.23%22430ZTSZoetis$162.92+0.6%1.16%34631BIIBBiogen$125.81-0.4%1.13%40632BGBunge Global$78.23+0.6%1.01%64933TWSTTwist Bioscience$28.26+0.4%1.01%1,26034SANBanco Santander$7.92-0.3%0.95%42135EXASExact Sciences$56.95+0.8%0.92%1,03636LEGNLegend Biotech$28.91-0.5%0.65%94237RCKTRocket Pharmaceuticals$6.27-4.4%0.46%3,40038CRSPCRISPR Therapeutics$36.86-1.8%0.33%468 Geographic ExposureUnited States85.5%France3.0%Ireland2.8%Germany2.5%Norway2.0%Switzerland1.4%Currency ExposureUSD78.1%EUR5.5%NOK2.0%Sector ExposureHealth Care56.0%Materials24.2%Technology8.6%Consumer Staples3.9%Consumer Discretionary2.6%Financials2.1%Industry ExposureBiotechnology34.5%Chemicals24.2%Health Care Equipment & Supplies16.4%Semiconductors & Semiconductor Equipment4.6%Software4.0%Food Products3.9%Health Care Providers & Services2.8%Textiles, Apparel & Luxury Goods2.6%Life Sciences Tools & Services2.3%Banks2.1%SubIndustry ExposureBiotechnology32.8%Life Sciences Tools & Services18.7%Specialty Chemicals17.9%Fertilizers & Agricultural Chemicals6.2%Semiconductors4.6%Application Software4.0%Agricultural Products2.8%Health Care Services2.8%Footwear2.6%Diversified Banks2.1%Agricultural Products & Services1.1% Related Companies and Tools Related Companies Avantis Inflation Focused Equity ETF Portfolio Cboe Vest 10 Year Interest Rate Hedge ETF Portfolio Invesco MSCI Green Building ETF Portfolio Harbor Transformative Technologies ETF Portfolio ProShares Ultra Nasdaq Cybersecurity ETF Portfolio NYLI Cleaner Transport ETF Portfolio Gabelli Automation ETF Portfolio Hypatia Women CEO ETF Portfolio YieldMax Semiconductor Portfolio Option Income ETF Portfolio Global X Solar ETF Portfolio This page (NYSEARCA:SYNB) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYNB Stock Free SYNB Stock Alerts